Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02230228
What this trial is testing

Phase 1 Safety Study of ALK-001 in Healthy Volunteers

Who this might be right for
Stargardt DiseaseAge-related Macular DegenerationOther Retinal Dystrophies
Alkeus Pharmaceuticals, Inc. 40
Large-scale testing (Phase 3)Study completedNCT03772665
What this trial is testing

Safety and Efficacy of Emixustat in Stargardt Disease

Who this might be right for
Stargardt Disease
Kubota Vision Inc. 194
Testing effectiveness (Phase 2)Ended earlyNCT00414206
What this trial is testing

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
CoMentis 343
Testing effectiveness (Phase 2)Looking for participantsNCT07668804
What this trial is testing

Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy

Who this might be right for
Geographic Atrophy Due to Age-Related Macular Degeneration
Theratocular Biotek Co. 31
Not applicableLooking for participantsNCT07577219
What this trial is testing

Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss

Who this might be right for
Low VisionCentral Visual ImpairmentMacular Degeneration
New England College of Optometry 12
Not applicableStudy completedNCT02224963
What this trial is testing

Macular Degeneration and Aging Study

Who this might be right for
Age-related Macular Degeneration
University of Rochester 216
Large-scale testing (Phase 3)Study completedNCT05161806
What this trial is testing

Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Sandoz 30
Not applicableWithdrawnNCT01731964
What this trial is testing

Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
VisionCare, Inc.
Not applicableStudy completedNCT04662944
What this trial is testing

A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 494
Post-approval studies (Phase 4)Ended earlyNCT00804206
What this trial is testing

Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

Who this might be right for
Macular Edema
Asociación para Evitar la Ceguera en México 15
Early research (Phase 1)Looking for participantsNCT07594236
What this trial is testing

Phase 1 Study of C.001 in Retinal Degeneration

Who this might be right for
Geographic AtrophyStargardt DiseaseRPE-mediated Maculopathy+1 more
Cellio Therapeutics Inc 15
Not applicableUnknownNCT02328209
What this trial is testing

Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Mie University 50
Testing effectiveness (Phase 2)Ended earlyNCT00857259
What this trial is testing

The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Choroidal Neo-Vascular Age-onset Macular DegenerationAge-related Macular Degeneration
Novartis Pharmaceuticals 16
Not applicableActive Not RecruitingNCT07390253
What this trial is testing

Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Vienna Institute for Research in Ocular Surgery 50
Not applicableActive Not RecruitingNCT05439759
What this trial is testing

Factors in Learning And Plasticity: Healthy Vision

Who this might be right for
Central Visual ImpairmentMacular Degeneration
University of Alabama at Birmingham 120
Testing effectiveness (Phase 2)Study completedNCT01162746
What this trial is testing

Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationNeovascularization, Choroidal
Medical University of Vienna 40
Not applicableStudy completedNCT05640895
What this trial is testing

Intravitreal Injection Site and Perceived Pain

Who this might be right for
Pain
The University of Texas Medical Branch, Galveston 53
Not applicableUnknownNCT00279695
What this trial is testing

Ultrasonic Evaluation of Ocular Tissues

Who this might be right for
GlaucomaTumorsAge-Related Macular Degeneration
Weill Medical College of Cornell University 150
Large-scale testing (Phase 3)Ended earlyNCT01601483
What this trial is testing

Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration

Who this might be right for
Nonexudative Age Related Macular Degeneration
MacuCLEAR, Inc. 22
Not applicableUnknownNCT05996822
What this trial is testing

Evaluation of Macular Edema After AcF Implant's Injection, 1 Month After the Last DXM Implant

Who this might be right for
Macular Edema
Nantes University Hospital 34
Next Page